AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Alnamet-GSR 2mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Alna Biotech Pvt Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Alnamet-GSR 2mg/500mg Tablet

Diabetol-Duo 2mg/500mg tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Diabetol-Duo should be administered with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary foods, juice) are essential preventative measures. Alcohol consumption elevates hypoglycemia risk and should be avoided. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring and potential blood tests (blood cell counts, liver function) are necessary as directed by your healthcare provider.

Primary Ingredients of Alnamet-GSR 2mg/500mg Tablet

The provided text is "undefined," offering no content to rephrase. Therefore, no rewritten text can be provided.

Uses of Alnamet-GSR 2mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Alnamet-GSR 2mg/500mg Tablet:

Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the 2mg/500mg Alnamet-GSR tablet whole; avoid crushing, chewing, or breaking it. Administer this medication with food.

Common Side effects of Alnamet-GSR 2mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Alnamet-GSR 2mg/500mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Alnamet-GSR 2mg/500mg tablet whole; do not break, crush, or chew it. Administer this medication with food.

How Alnamet-GSR 2mg/500mg Tablet works:

Each Alnamet-GSR 2mg/500mg tablet unites glimepiride (a sulfonylurea) and metformin (a biguanide), two agents combating elevated blood sugar. Glimepiride stimulates pancreatic insulin secretion, thus reducing blood glucose. Metformin acts triply: it diminishes hepatic glucose production, slows intestinal glucose uptake, and enhances insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Alcohol consumption alongside Alnamet-GSR 2mg/500mg tablets poses a safety risk.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Alnamet-GSR 2mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers before recommending this medication. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Breastfeeding mothers should not use Alnamet-GSR 2mg/500mg tablets. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Alnamet-GSR 2mg/500mg tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. For individuals with severe kidney disease, Alnamet-GSR 2mg/500mg tablets are contraindicated. Regular kidney function assessments are recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Alnamet-GSR 2mg/500mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, initiation should be at a low dosage; however, its use is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Alnamet-GSR 2mg/500mg Tablet :

Should you forget to take your Alnamet-GSR 2mg/500mg Tablet, administer it immediately upon remembering. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Alnamet-GSR 2mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Alnamet-GSR 2mg/500mg Tablet

Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Alnamet-GSR 2mg/500mg Tablets can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency characterized by excessive blood lactic acid. This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume significant amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue use and seek immediate medical attention.
Alnamet-GSR 2mg/500mg tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is not suitable for type 1 diabetes.
Alnamet-GSR 2mg/500mg Tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use may result in vitamin B12 deficiency.
Prolonged use of Alnamet-GSR 2mg/500mg tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 intake, at least annually, is recommended by some researchers.
Alnamet-GSR 2mg/500mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Alnamet-GSR 2mg/500mg tablets with alcohol is unsafe. This combination can cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Alnamet-GSR 2mg/500mg Tab...
65
MRP 75
13% off